104 related articles for article (PubMed ID: 33620089)
41. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
[TBL] [Abstract][Full Text] [Related]
42. Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
Khan NI; Cisterne A; Devidas M; Shuster J; Hunger SP; Shaw PJ; Bradstock KF; Bendall LJ
Leuk Lymphoma; 2008 Apr; 49(4):710-8. PubMed ID: 18398738
[TBL] [Abstract][Full Text] [Related]
43. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
[TBL] [Abstract][Full Text] [Related]
44. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.
Willemse MJ; Seriu T; Hettinger K; d'Aniello E; Hop WC; Panzer-Grümayer ER; Biondi A; Schrappe M; Kamps WA; Masera G; Gadner H; Riehm H; Bartram CR; van Dongen JJ
Blood; 2002 Jun; 99(12):4386-93. PubMed ID: 12036866
[TBL] [Abstract][Full Text] [Related]
45. DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia.
Borssén M; Nordlund J; Haider Z; Landfors M; Larsson P; Kanerva J; Schmiegelow K; Flaegstad T; Jónsson ÓG; Frost BM; Palle J; Forestier E; Heyman M; Hultdin M; Lönnerholm G; Degerman S
Clin Epigenetics; 2018; 10():31. PubMed ID: 29515676
[TBL] [Abstract][Full Text] [Related]
46. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
[TBL] [Abstract][Full Text] [Related]
47. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K;
Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137
[TBL] [Abstract][Full Text] [Related]
48. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia.
Moorman AV
Blood Rev; 2012 May; 26(3):123-35. PubMed ID: 22436535
[TBL] [Abstract][Full Text] [Related]
49. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
51. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
52. Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse.
Green E; McConville CM; Powell JE; Mann JR; Darbyshire PJ; Taylor AM; Stankovic T
Blood; 1998 Aug; 92(3):952-8. PubMed ID: 9680364
[TBL] [Abstract][Full Text] [Related]
53. Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Wehrli LA; Braun J; Buetti LN; Hagleitner N; Hengartner H; Kühne T; Lüer S; Ozsahin H; Popovic MB; Niggli FK; Betts DR; Bourquin JP
Cancer Genet Cytogenet; 2009 Feb; 189(1):29-36. PubMed ID: 19167609
[TBL] [Abstract][Full Text] [Related]
54. Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute lymphoblastic leukaemia.
Moreira LBP; Queiróz RP; Suazo VK; Perna E; Brandalise SR; Yunes JA; Tone LG; Scrideli CA
Br J Haematol; 2019 Nov; 187(3):e58-e61. PubMed ID: 31483479
[No Abstract] [Full Text] [Related]
55. Clinical significance of SH2B3 (LNK) expression in paediatric B-cell precursor acute lymphoblastic leukaemia.
Yano M; Imamura T; Asai D; Deguchi T; Hashii Y; Endo M; Sato A; Kawasaki H; Kosaka Y; Kato K; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K
Br J Haematol; 2018 Oct; 183(2):327-330. PubMed ID: 29082511
[No Abstract] [Full Text] [Related]
56. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
[TBL] [Abstract][Full Text] [Related]
57. Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling.
Yeoh AE; Li Z; Dong D; Lu Y; Jiang N; Trka J; Tan AM; Lin HP; Quah TC; Ariffin H; Wong L
Br J Haematol; 2018 Jun; 181(5):653-663. PubMed ID: 29808917
[TBL] [Abstract][Full Text] [Related]
58. First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia.
Fazio G; Massa V; Grioni A; Bystry V; Rigamonti S; Saitta C; Galbiati M; Rizzari C; Consarino C; Biondi A; Selicorni A; Cazzaniga G
J Clin Pathol; 2019 Aug; 72(8):558-561. PubMed ID: 30948435
[TBL] [Abstract][Full Text] [Related]
59. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
60. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
